Hosted on MSN1mon
Have the New Pulmonary Hypertension Drugs Changed the Game?In March, just days prior to sotatercept's approval, macitentan/tadalafil become the first single-tablet dual therapy, comprising an ERA and PDE-5 inhibitor together, to gain an indication for ...
Hosted on MSN11mon
J&J wins FDA nod for blood vessel disorder therapy, OpsynviAccordingly, Opsynvi, a single tablet comprising the endothelin receptor antagonist macitentan and the phosphodiesterase 5 (PDE5) inhibitor tadalafil, will be indicated in the U.S. for adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback